1. Home
  2. SPCB vs ELEV Comparison

SPCB vs ELEV Comparison

Compare SPCB & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • ELEV
  • Stock Information
  • Founded
  • SPCB 1988
  • ELEV 2019
  • Country
  • SPCB Israel
  • ELEV United States
  • Employees
  • SPCB N/A
  • ELEV N/A
  • Industry
  • SPCB Semiconductors
  • ELEV Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • ELEV Health Care
  • Exchange
  • SPCB Nasdaq
  • ELEV Nasdaq
  • Market Cap
  • SPCB 21.1M
  • ELEV 22.0M
  • IPO Year
  • SPCB N/A
  • ELEV 2021
  • Fundamental
  • Price
  • SPCB $6.66
  • ELEV $0.36
  • Analyst Decision
  • SPCB Strong Buy
  • ELEV Buy
  • Analyst Count
  • SPCB 1
  • ELEV 6
  • Target Price
  • SPCB $18.00
  • ELEV $2.94
  • AVG Volume (30 Days)
  • SPCB 351.1K
  • ELEV 996.3K
  • Earning Date
  • SPCB 05-14-2025
  • ELEV 05-16-2025
  • Dividend Yield
  • SPCB N/A
  • ELEV N/A
  • EPS Growth
  • SPCB N/A
  • ELEV N/A
  • EPS
  • SPCB 0.38
  • ELEV N/A
  • Revenue
  • SPCB $27,635,000.00
  • ELEV N/A
  • Revenue This Year
  • SPCB $19.49
  • ELEV N/A
  • Revenue Next Year
  • SPCB $10.57
  • ELEV N/A
  • P/E Ratio
  • SPCB $16.79
  • ELEV N/A
  • Revenue Growth
  • SPCB 4.01
  • ELEV N/A
  • 52 Week Low
  • SPCB $2.55
  • ELEV $0.22
  • 52 Week High
  • SPCB $18.95
  • ELEV $4.33
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 51.58
  • ELEV 55.46
  • Support Level
  • SPCB $5.43
  • ELEV $0.33
  • Resistance Level
  • SPCB $8.25
  • ELEV $0.36
  • Average True Range (ATR)
  • SPCB 0.55
  • ELEV 0.03
  • MACD
  • SPCB 0.07
  • ELEV 0.00
  • Stochastic Oscillator
  • SPCB 42.20
  • ELEV 68.73

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

Share on Social Networks: